Marshall Wace LLP Makes New $3.14 Million Investment in Doximity, Inc. (NASDAQ:DOCS)

Marshall Wace LLP bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 58,867 shares of the company's stock, valued at approximately $3,143,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Global Retirement Partners LLC increased its stake in shares of Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after buying an additional 250 shares in the last quarter. Optimum Investment Advisors acquired a new stake in shares of Doximity in the fourth quarter valued at $43,000. Finally, Morse Asset Management Inc acquired a new stake in shares of Doximity in the third quarter valued at $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 37.40% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DOCS. Bank of America raised their target price on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research note on Monday, January 6th. KeyCorp decreased their price target on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. The Goldman Sachs Group raised their price target on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Truist Financial decreased their price target on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a report on Thursday, April 10th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $65.39.

Doximity Trading Up 0.2 %

Shares of NASDAQ:DOCS traded up $0.10 during trading on Monday, hitting $56.75. 1,281,408 shares of the company's stock traded hands, compared to its average volume of 1,990,038. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The company has a market cap of $10.59 billion, a price-to-earnings ratio of 56.75, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The company has a 50-day moving average price of $60.30 and a 200-day moving average price of $56.37.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.